Disclosed is a novel anti-enterovirus 71 (EV71) 1,2,5-thiadiazolidine-1,1-dioxide derivative or a pharmaceutically acceptable salt thereof; and specifically, a compound represented by formula (II) or a pharmaceutically acceptable salt thereof.
COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS
申请人:Hart Terance William
公开号:US20090048230A1
公开(公告)日:2009-02-19
The present invention relates to the use of a 2-cyanopyrimidine compound of the formula
wherein
R
1
, R
2
, R
3
and X are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in tautomeric form, as an inhibitor of the activity of cathepsin S.
N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
申请人:Bayer Pharma Aktiengesellschaft
公开号:US09309198B2
公开(公告)日:2016-04-12
The present application relates to novel substituted 2-(piperidin-1-yl)acetamide derivatives, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular diseases.
PYRIMIDOPYRROLE SPIRO COMPOUNDS AND DERIVATIVES THEREOF AS DNA-PK INHIBITORS
申请人:Medshine Discovery Inc.
公开号:EP4063371A1
公开(公告)日:2022-09-28
Provided are a class of DNA-PK inhibitor, and specifically, a compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and use thereof in the preparation of DNA-PK inhibitor-related drugs.